International Immunology, Vol. 13, No. 11, 1433-1442,
November 2001
© 2001 Japanese Society for Immunology
Signals delivered through TCR instruct IL-12 receptor (IL-12R) expression: IL-12 and tumor necrosis factor-
synergize for IL-12R expression at low antigen dose
Molecular Immunogenetics and Vaccine Research Section, Metabolism Branch, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA
Correspondence to: J. A. Berzofsky
Regulation of the IL-12 receptor (IL-12R) ß2 chain has been suggested to function as a molecular switch in determining T cell phenotype. However, because most studies have been carried out under conditions in which cell proliferation was occurring, it has been difficult to distinguish between instructive and selective mechanisms in regulating this key receptor. Here, in the course of trying to understand the mechanism for synergy between IL-12 and TNF-
in up-regulating IFN-
production, we find that when the stimulus through the TCR is too weak to induce cell proliferation, which would be needed for selection, IL-12 and TNF- synergize to up-regulate not only IFN-, but also the IL-12Rß2 chain, which triggers IFN- production. Neither cytokine alone was sufficient. This observation held true both in the absence of antigen-presenting cells (APC), when the stimulus was anti-CD3 on plastic, and in the presence of APC presenting ovalbumin peptide to TCR-transgenic T cells. In contrast, when the TCR signal was stronger, no cytokines were necessary to up-regulate the IL-12R. Our results support the strength of signal model in instructing Th phenotype, and suggest both an instructive role and, later, through the production of IFN-, a selective role, of this synergistic combination of cytokines in the preferential differentiation and expansion of Th1 cells.
Keywords: cellular activation, cytokine, cytokine receptors, T lymphocyte, Th1/Th2
Transmitting editor: Warren J. Leonard
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. J. Welsh, A. N. Abbott, S.-A. Hwang, J. Indrigo, L. Y. Armitige, M. R. Blackburn, R. L. Hunter, and J. K. Actor A role for tumour necrosis factor-{alpha}, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response Microbiology, June 1, 2008; 154(6): 1813 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. G. Ovsyannikova, R. M. Jacobson, N. Dhiman, R. A. Vierkant, V. S. Pankratz, and G. A. Poland Human Leukocyte Antigen and Cytokine Receptor Gene Polymorphisms Associated With Heterogeneous Immune Responses to Mumps Viral Vaccine Pediatrics, May 1, 2008; 121(5): e1091 - e1099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-X. Zhang, S. Yu, B. Gran, J. Li, I. Siglienti, X. Chen, D. Calida, E. Ventura, M. Kamoun, and A. Rostami Role of IL-12 Receptor {beta}1 in Regulation of T Cell Response by APC in Experimental Autoimmune Encephalomyelitis J. Immunol., November 1, 2003; 171(9): 4485 - 4492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bao, Y. Yang, H.-S. Jun, and J.-W. Yoon Molecular Mechanisms for Gender Differences in Susceptibility to T Cell-Mediated Autoimmune Diabetes in Nonobese Diabetic Mice J. Immunol., May 15, 2002; 168(10): 5369 - 5375. [Abstract] [Full Text] [PDF]
|
|